MedInnovate Limited is registered in England & Wales No. 05318138 © MedInnovate 2011
Creating, developing and transforming life science businesses
Our investments
We make strategic investments in emerging companies that we believe have outstanding products or services that address significant global markets and excellent management teams. This often involves supporting the establishment of new businesses around exciting technologies. Having made such investments the MedInnovate team support the business through mechanisms such as taking Non-Executive Board seats, creating networks and introductions and advising on strategies and financing options. We are open to approaches from exciting start-up companies seeking investment, and to inquiries about companies within our portfolio.
BioAnaLab is a specialised biopharmaceutical Contract Research Organisation that helps pharmaceutical companies complete trials successfully by analysing biological therapeutics such as antibodies, vaccines, recombinant proteins, cytokines and growth hormones. It was successfully sold in 2009 to Millipore achieving a significant return for investors.
Glide Pharma (previously CareTek Medical) is a specialty pharmaceutical company developing products for easy, safe and convenient delivery of pharmaceuticals and vaccines using its proprietary Glide SDI – the Solid Dose Injector. By being much less invasive than traditional injection methods, Glide improves the treatment experience of both patients and carers and, by allowing the injection of solid formulations, opens up a wide range of therapeutic options for new and existing treatments.
Kinapse was founded in 2005 and it provides consulting and outsourcing services to global life sciences industries. This business now has over 100 employees in the UK, India and the US and an extensive network of consulting partners. It continues to grow its revenues and profitability and now serves many of the world's leading pharmaceutical companies and regulatory agencies.
MicroVisk is developing micro electro-mechanical sensors that accurately measure fluid viscosity. An early application is in measuring blood clotting, potentially enabling more accurate measurements of dosages in anti-clotting therapies.
The Native Antigen Company specialises in the purification of viral and bacterial antigens for in vitro diagnostics manufacturers. It also provides an adenovirus purification capability and a screening service for anti-cancer drug compounds.
Oxtex was founded in 2011. It is a spinout medical device company from the University of Oxford that is developing self-inflating tissue expanders for temporary surgical implantation. Their technology allows accurate control of the speed, extent and direction of expansion to enable improved patient outcomes from surgery.
Parafricta is aiming to become the leading brand for low-friction fabric in the medical healthcare sector, just as Goretex is for breathable waterproofing and Lycra is for stretchable sports wear. Proven to be significantly more effective than the traditionally used silk, but much more durable and washable at high temperatures, Parafricta fabric has the properties required for repeated use in demanding medical situations. Garments and bedding made from the unique ultra low-friction fabric are used to protect patient skin when there is a risk of damage to highly sensitive areas, resulting in bedsores or pressure ulcers.
PsiOxus Therapeutics was formed from the merger of Hybrid and Myotec. It has has products which treat disease and potentiate vaccines. Lead products include an oncolytic virus and an anabolic agent for treating cachexia.